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Abstract
Human nondisjunction errors in oocytes are the leading cause of pregnancy loss, and for
pregnancies that continue to term, the leading cause of intellectual disabilities and birth
defects. For the first time, we have conducted a candidate gene and genome-wide associa-
tion study to identify genes associated with maternal nondisjunction of chromosome 21 as a
first step to understand predisposing factors. A total of 2,186 study participants were geno-
typed on the HumanOmniExpressExome-8v1-2 array. These participants included 749 live
birth offspring with standard trisomy 21 and 1,437 parents. Genotypes from the parents and
child were then used to identify mothers with nondisjunction errors derived in the oocyte and
to establish the type of error (meiosis I or meiosis II). We performed a unique set of subgroup
comparisons designed to leverage our previous work suggesting that the etiologies of meio-
sis I and meiosis II nondisjunction differ for trisomy 21. For the candidate gene analysis, we
selected genes associated with chromosome dynamics early in meiosis and genes associ-
ated with human global recombination counts. Several candidate genes showed strong
associations with maternal nondisjunction of chromosome 21, demonstrating that genetic
variants associated with normal variation in meiotic processes can be risk factors for nondis-
junction. The genome-wide analysis also suggested several new potentially associated loci,
although follow-up studies using independent samples are required.
Author summary
Approximately one of every 700 babies is born with trisomy 21—an extra copy of chromo-
some 21. Trisomy 21 is caused by the failure of chromosomes to segregate properly
during meiosis, generally in the mother. Past studies have defined altered patterns of
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recombination along nondisjoined chromosomes as risk factors for human nondisjunc-
tion and model systems have clearly shown that specific genes involved recombination
and other early meiotic processes play a role in the fidelity of chromosome segregation.
However, no genome-wide genetic study (GWAS) has ever been conducted using mater-
nal human nondisjunction as the disease phenotype. This study takes the first step to
understand predisposing factors. We used chromosome 21 genotypes from the parents
and child to identify mothers with nondisjunction errors derived in the oocyte and to
establish the type of error (meiosis I or meiosis II). We then conducted a unique set of
subgroup comparisons designed to leverage our previous work that shows that the etiolo-
gies of meiosis I and meiosis II nondisjunction differ for trisomy 21. Both the candidate
gene study and the GWAS provide evidence that meiotic-specific structures and processes
are vulnerable to genetic variants that lead to increased risk of human chromosome
nondisjunction.
Introduction
Correct segregation of chromosomes during the two successive meiotic divisions is essential
for the formation of haploid gametes. At least 10% of human pregnancies produce aneuploid
embryos with too many or too few chromosomes, the majority of which are lost during preg-
nancy. If they survive to term, many have severe congenital defects and developmental and
intellectual disability. Thus, meiotic nondisjunction is the leading cause of pregnancy loss and
birth defects in humans and an important limiting factor in women’s reproductive life span.
(reviewed in [1–4]).
In humans, meiosis in females is highly prone to chromosome segregation errors [i.e., non-
disjunction or premature separation of sister chromatids (PSSC)] and these errors increase
exponentially with increasing maternal age. The differences between the development of
oocytes and sperm clearly influence susceptibility for meiotic nondisjunction. Most impor-
tantly, they work on different timelines. In both sexes, meiosis starts with an initial step of
DNA replication and the establishment of sister chromatid cohesion, followed by synapsis and
recombination between homologous chromosomes. Homologs then separate at the end of
meiosis I (MI), whereas sister chromatids separate in meiosis II (MII). Spermatogenesis begins
after puberty and cells entering meiosis move from one stage to the other without delay. In
contrast, oogenesis begins during fetal development and is arrested in prophase I after chro-
mosomes synapse and recombine. MI resumes in the woman’s adult life just before the ovula-
tion; MI is completed and the first polar body is extruded. MII begins but arrests for a short
period as the oocyte travels through the Fallopian tubes, and is only completed if the oocyte is
fertilized. Thus, meiosis in females extends over a 10 to 50 year period; the age of the woman at
conception reflects the age of the oocyte, and basically the period of arrest in MI. Given the
mechanistic differences and temporal separation of maternal MI and MII, it is not surprising
that associated risk factors differ for MI and MII nondisjunction errors (reviewed in [5]).
Trisomy 21 has become an important resource to understand meiotic nondisjunction in
humans, as it is one of the few aneuploid conditions that survives to term. However, even for
trisomy 21, involving the smallest human autosome, about 50–80% conceptions are estimated
to be lost during pregnancy [6, 7]. Using chromosome 21 genetic markers to categorize the
type of meiotic error among live births with trisomy 21, over 90% are derived from errors in
the oocyte, of which at least 75% are estimated to be initiated in MI and about 25% in MII
(e.g., [8]).
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In this study, our goal was to discover genetic variants that increase the risk for maternal
nondisjunction of chromosome 21 using both a candidate gene approach and a genome-wide
association study. We focused on candidate genes that have been associated with chromosome
dynamics early in meiosis. Accurate segregation depends on the coordinated control of sister
chromatid cohesion with chromosome synapsis and the assembly of the synaptonemal com-
plex (SC) and, within these structures, meiotic recombination [9, 10]. Below we provide a brief
overview of the role of some of the important meiotic genes that mediate these processes, and
that we have examined in the present study. Bolcun-Filas and Schimenti [9] have summarized
the meiotic defects that are observed in the associated mutant mouse models.
In a meiotic cell, DNA is organized as an array of loops along a proteinaceous axis. The axes
are composed of the meiosis-specific synaptonemal complex, in association with condensin/
cohesin complexes. Several of the components of meiotic cohesin are meiosis-specific, includ-
ing those encoded by SMC1β, REC8, RAD21L, and STAG3. The SC brings homologous chro-
mosomes into close proximity and promotes recombination and chiasmata formation [11].
The mature SC is a tripartite structure, composed of two parallel axial/lateral elements that
bind to each homolog and a central element, with transverse filaments joining the individual
axial/lateral elements [12, 13]. SYCP2 and SYCP3 are components of the axial/lateral elements.
SYCP1 is a component of the transverse filaments and components of the central element are
encoded by SYCE1, SYCE2, SYCE3, and TEX12. In addition to these structural sub-units,
HORMAD1 and HORMAD2 code for proteins that load onto axes of meiotic chromosomes
throughout early prophase I but are removed upon synapsis, a process that depends on the
presence of TRIP13 [14]. In general, HORMAD1 and HORMAD2 play a role in coordinating
progression of chromosome synapsis with meiotic recombination [15].
Meiotic recombination is initiated by programmed DNA double-strand breaks (DSBs) that
occur as the meiotic chromosome axes develop early in prophase I. These breaks are generated
by the SPO11 protein and its interacting partners MEI1, MEI4 and REC114 (reviewed in Cole
et al. [16]). The DSBs are processed to generate single-stranded DNA that is bound by strand-
exchange proteins DMC1 (meiosis specific) and RAD51 (ubiquitously expressed). The single-
stranded DNA then engages in homology search. Proper function of DMC1 requires interac-
tions with several meiotic accessory proteins, one of which is MND1. MND1, complexed with
HOP2, stabilizes the DMC1 filaments on the resected end of the DSBs. This complex also
increases the ability of the pre-synaptic filament to capture the double-stranded DNA
(reviewed in Sansam and Pezza [17]).
As homologs synapse, so-called early recombination nodules transiently associate with
ZMM proteins, including DNA mismatch repair proteins MSH4 and MSH5. Subsequently, a
proportion of these are converted into late recombination nodules, detected by the mismatch
repair proteins MLH1 and MLH3, and representing the vast majority of crossovers [18–22]. In
addition, EXO1 and BLM function in crossover regulation, and with MLH1 and MLH3,
appear to play a role in the crossover pathway that is subject to crossover interference
(reviewed in Manhart and Alani [23]).
In addition to these candidate genes, we chose another group of genes that have been asso-
ciated with the amount of global meiotic recombination in humans. The motivation for these
candidates is based on the altered recombination patterns observed along nondisjoined chro-
mosomes, a well-established predisposing factor for maternal nondisjunction of almost all
human chromosomes studied to date (reviewed in [24]). Specifically for maternal chromo-
some 21 nondisjunction, altered meiotic recombination patterns are associated with both MI
and MII error types [25–29]. For maternal MI-derived trisomy 21, about 40–47% of MI cases
are derived from oocytes with no meiotic exchange [25, 27, 30]. Among those with a single
exchange, the majority of exchanges occur in the telomeric region of chromosome 21. MII
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errors are associated with pericentromeric exchanges [25, 27, 29, 30]. This apparent effect of
an MI process–recombination–on MII nondisjunction suggests that at least a portion of so-
called MII errors may have their origin in MI. In addition, there is evidence that genome-wide
recombination counts in oocytes with a MI nondisjunction error of chromosome 21 are
reduced compared to oocytes with normal meiosis [31, 32]. Also, previous studies indicate
that oocyte-specific dysregulation of global recombination may contribute to the nondisjunc-
tion event [31]. Thus, we chose candidate genes identified in the largest GWAS study of mei-
otic recombination conducted on humans, a study based on 71,929 parent-offspring pairs
from Iceland [33]. They found evidence for 13 variants in eight regions that were associated
with genome-wide recombination counts.
For both the candidate gene and genome-wide association studies, we took a unique
approach by using several different GWAS group comparisons (Table 1). These comparisons
were crafted to address the likelihood that there are both distinct genetic factors influencing
MI and MII nondisjunction and common factors affecting both. In addition, some of our anal-
yses target the conflated phenotype of nondisjunction with survival to term. Study design
issues are discussed in more detail below.
Methods
Study sample
Our study participants included 749 live born offspring with free (non-translocation), mater-
nally-derived trisomy 21 (both full and mosaic trisomy 21 were included) and their available
biological parents. In almost all instances, the trisomy was confirmed by karyotype, although
in some it was confirmed by birth record or parent report. Recruitment occurred in the U.S.
by multiple sites since 1989, when the first population-based study was initiated. Recruitment
for these population-based studies used birth surveillance systems to identify infants born with
Down syndrome (details are provided in Freeman et al. [8]). Later, our recruitment strategy
was not population-based, but instead a convenience sample of families with Down syndrome
identified through our network of assessment sites, social and website media, and parent
groups. Using self-reported race/ethnicity, 72% reported as White, 4% as Hispanic descent, 2%
as African/African-American or Asian descent and about 23% with other or unknown
descent.
Ethics statement
Participants were recruited from several geographic areas with the collaboration of several
institutions, including Arkansas (University of Arkansas for Medical Sciences, Arkansas Cen-
ter for Birth Defects Research and Prevention, Arkansas Children’s Hospital, Arkansas Repro-
ductive Health Monitoring Systems), California (California Birth Defects Monitoring
Table 1. Description of primary analyses and associated sample sizes.
Analysis Analysis groups Sample size Contrast able to detect:
Logistic regression Mothers vs. fathers 705 vs. 645 Maternal NDJ and survival to term
. . . MI mothers vs. fathers 535 vs. 645 MI-specific effects and survival to term
. . . MII mothers vs. fathers 157 vs. 645 MII- specific effects and survival to term
. . . MI mothers vs. MII mothers 535 vs. 157 MI- or MII-specific effects
TDT All complete case trios 615 trios Survival to term
NDJ: nondisjunction; MI: maternal MI nondisjunction error; MII: maternal MII nondisjunction error.
https://doi.org/10.1371/journal.pgen.1008414.t001
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Program, Public Health Institute), Georgia (Department of Human Genetics, Emory Univer-
sity; Centers for Disease Control and Prevention), Iowa (University of Iowa, Registry for Con-
genital and Inherited Disorders), New Jersey (New Jersey Department of Health and Senior
Services; Special Child Health Services Registry; Eagleton Institute), and New York (New York
State Department of Health Congenital Malformations Registry). Each recruitment site
obtained IRB approval for their protocol, consent forms, and data sharing during the project
period from their respective institutions. All samples were collected under written consent by
each participant or their legal guardian. Emory University was the site for the data and biore-
pository. They obtained IRB approval for all sample processing and de-identified sample sub-
mission to the Center for Inherited Disease Research genotyping service (Emory School of
Medicine IRB number IRB00005100). IRB approvals for genotyping samples and uploading to
dbGaP were approved prior to the initiation of that genotyping project (dbGaP: phs000718).
Genotyping
DNA samples were obtained from lymphoblastoid cell lines (LCLs) (36.8%), saliva (23.7%),
buffy coat (15.7%), whole blood (13%), unknown source (i.e., no record available) (8.4%), and
buccal cell (0.09%). The remaining 2.2% of genotyped samples were HapMap controls derived
from LCLs that were used by the Center for Inherited Disease Research (CIDR) for quality
control (QC). The samples were genotyped in batches corresponding to 96-well plates and
each plate contained two study duplicates and HapMap controls. Duplicates were randomly
selected from all samples with sufficient DNA. Families were randomly distributed across
plates with all members of each family on the same plate.
Genotyping was performed on the Illumina HumanOmniExpressExome-8v1-2 array by the
Center for Inherited Disease Research (CIDR). The algorithm used for calling genotypes was
GenomeStudio version 2011.1, Genotyping Module version 1.9.4 and GenTrain version 1.0.
Genotype data that passed initial QC at CIDR were released to the Quality Assurance (QA)/
QC) analysis team at the University of Washington Genetics Coordinating Center (UWGCC)
for data cleaning and imputation. Details of these procedures can be found in Laurie et al. [34]
and all data are available in dbGaP along with specifics of genotyping and QC (dbGaP:
phs000718). After QC, genotypes were available for 2,186 unique study participants. We fil-
tered SNPs based a deviation of Hardy-Weinberg equilibrium (HWE) at p< 10−6. Overall, the
median call rate was 99.86% and the error rate estimated from 53 pairs of study sample dupli-
cates is 1x10-4. All samples had a missing call rate< 2%. The percent of SNPs with a minor
allele frequency (MAF) of< 2% was 30% for the autosomes and 32.1% for the X chromosome.
This calculation was based on all study participants for SNPs not located on chromosome 21
and on only study parent samples for SNPs on chromosome 21. Trisomic genotypes for all 749
children in the study were called from raw genotyping data with previously-developed meth-
ods [35].
Possible chromosomal abnormalities beyond trisomy 21 were examined as possible artifacts
of the use of DNA from LCLs. This was done using Log R Ratio" (LRR) and “B Allele Fre-
quency" (BAF) [36, 37] and applying the methods outlined in Laurie et al. [38]. Regions or
chromosomes containing identified anomalies were excluded for genotype imputation pur-
poses (see below). For chromosomes other than chromosome 21, 50 large anomalies were
identified, of which 15 were filtered out of the dataset by setting genotypes in the identified
region to missing. In addition, Mendelian inconsistencies were examined and one additional
family was identified to have a genotype pattern consistent with uniparental chromosome 16
in the offspring. Genotypes at this chromosome were also set to missing.
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Seven participants with neither parent genotyped were excluded from subsequent analyses.
Thus in the remaining 742 families, genotypes were available for both the child and either the
mother only (n = 95), the father only (n = 17), or both parents (n = 630).
Adjustment for population structure
Binary trait analyses using logistic regression are our primary statistical approach in this
GWAS study. To adjust for population structure, we first used principal components analysis
(PCA) as described by Patterson et al. [39], and implemented in R (SNPRelate package). SNPs
used for PCA were selected by LD pruning from an initial pool that included all non-chromo-
some 21 autosomal SNPs with a missing call rate< 5% and MAF > 5%. In addition, the 2q21
(LCT), HLA, 8p23, and 17q21.31 regions were excluded from the initial pool. The first three
eigenvectors were used in subsequent analyses.
Imputation
The UWGCC used IMPUTE2 software [40] to perform genotype imputation. Details of their
methods and QC are available at dbGaP:phs000718. The worldwide reference panel of 1,092
samples from the 1000 Genomes Project’s Phase I integrated variant set [41] was used for
imputation. We included only imputed variants with a quality metric of� 0.3, as previously
recommended [42].
Phenotyping
Our primary association studies were based on mothers who had a live birth with full or
mosaic trisomy 21 as determined by karyotype and then determined to be due to a maternal
nondisjunction error based on the characterization of the chromosome 21 genotype contribu-
tions from parent to the child with trisomy 21. Genotypes were obtained from the Illumina
HumanOmniExpressExome-8v1-2 array and from previously genotyped variants along chro-
mosome 21 using both STRs and SNPs [27, 29] The groups based on maternal nondisjunction
errors were compared with fathers of the children with trisomy 21 who represent a random
group of individuals from the population.
Methods for defining the type of nondisjunction errors are described in detail in our previ-
ous work (e.g.,[27, 29]). Briefly, parental origin of the meiotic error (maternal or paternal) was
first determined by establishing the contribution of informative parental chromosome 21
genotypes to the child with trisomy 21. In families with both parents genotyped and where the
parent of origin was unambiguously confirmed to be the mother (the vast majority of these
families), we defined the meiotic stage of origin. We scored the genotype at each informative
SNP and STR marker on chromosome 21q as either reduced to homozygosity (R) or not (N),
according to whether the mother transmitted two identical or two different alleles, respec-
tively, to her child at that locus. The meiotic stage of nondisjunction (MI or MII) was called
according to the zygosity at the loci most proximal to the centromere (N or R, respectively). In
a few cases (n = 7), MII nondisjunction was called on the basis of a single, well-genotyped R
SNP nearest the centromere (followed by a series of N SNPs), but because of the dense SNP
genotyping on the chip, stage was more typically supported by many markers.
In families with only one parent genotyped, a slightly different approach was required, as
missing parental data led to some markers that are partially informative, but not dispositive of
zygosity. Briefly, we considered the ratio of information in the SNPs near the centromere, and
called each case as MI or MII depending on the ratio. The threshold for this ratio was selected
by performing an experiment with the complete trios; for each complete trio, we masked the
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genotype of one parent, calculated the ratio described above, and found the cutoff that opti-
mized the predictive accuracy.
Lastly, when all informative markers in the parent of origin were reduced to homozygosity
along 21q, the origin of error was inferred to be a post-zygotic, mitotic error and the case was
excluded from this study, consistent with previous studies [25]. However, we recognize that a
proportion of these cases may be MII nondisjunction errors with no recombination.
Analysis
Sample size. As described above, samples from 2,186 participants were genotyped for this
study, comprising 749 children and 1,437 parents. Participants with unresolved identity swaps,
probands (children) with neither parent genotyped, and mothers in cases of potentially mitoti-
cally-arising trisomy were excluded from GWAS. After this filtering, 705 mothers and 645
fathers were retained for analysis, comprising 612 complete parent-child trios. Meiotic stage of
origin for trisomy was determined to be MI in 535 cases, MII in 157 cases, and was not deter-
mined in 13 cases. Sample sizes for our analysis groups are reported in Table 1.
Association studies. We performed five primary GWAS analyses (summarized in
Table 1). The comparison for all mothers vs. fathers can identify maternal genetic factors influ-
encing nondisjunction either in MI or MII (or, more powerfully, in both). As noted in the
Introduction, some genetic factors affecting MI nondisjunction may be shared with MII non-
disjunction. Comparison of MI-only or MII-only mothers with fathers can identify maternal
genetic factors influencing MI nondisjunction or MII nondisjunction, respectively. All three
of these comparisons will also detect maternally-derived variants affecting survival of the
infant to term. We chose to use fathers within our own study as controls rather than turning to
external controls because of the significant problem with confounding (chip and study effects)
that is introduced when cases genotyped in one study are compared to controls genotyped in
another.
However, one risk of using fathers as controls is that in theory the three analyses that com-
pare mothers to fathers may also identify spurious associations due to comparing females to
males. We tested this by running a female vs. male GWAS in a large additional dataset and
comparing our results to those. The dataset we used was a subset of the COHRA study [43];
this study targeted dental phenotypes, but participants were selected in a community-based
setting without regard to phenotype. We used 456 male and 494 female unrelated self-identi-
fied white adults in order to have a sample size comparable to the current study. By using sex
as the outcome measure in a sample that was unselected with regard to phenotype, this analysis
gave us a set of results to compare to our trisomy dataset in order to determine whether any of
our trisomy results might instead be male vs. female artifacts. The female vs. male analysis in
the COHRA dataset did not result in any unusually significant differences (lambda = 0.94).
None of the GWAS loci or candidate genes described in the results section appeared among
the largest differences between males and females in the COHRA dataset. The Manhattan plot
and QQ plots are provided in the Supporting Information (S1 Fig), as well as results from the
COHRA analysis in our candidate genes (S1 Table).
The fourth comparison involves MI vs. MII mothers. This comparison has the potential to
identify unique factors for MI or MII nondisjunction without confounding by trisomy 21 sur-
vival; that is, both groups of mothers had a live birth child with trisomy 21.
For the fifth analysis, we conducted a transmission disequilibrium test (TDT) [44]. This test
examines the association between the child’s genotype and the dual phenotype of nondisjunc-
tion and survival to term. Our prior hypothesis is that this test is best for identifying fetal “sur-
vival genes.” If there is association between maternal genotype and either nondisjunction or
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survival, this test can in theory identify it, but the association would be weakened. We did not
perform this test for the candidate genes, since they were chosen as candidates for nondisjunc-
tion, not for survival. For the nondisjoined chromosome 21, we used a trisomic TDT, previ-
ously developed by our group [45].
For all analyses except the TDT, we used the logistic regression model logit(p) = SNP + PC1
+ PC2 + PC3, where SNP is encoded additively and PC1, PC2, and PC3 are the first three prin-
cipal components of ancestry. The X chromosome was not examined because our primary
comparative analyses involved mothers vs. fathers.
For all analyses, we filtered out SNPs with MAF < 1% or with extreme departure from
HWE. Imputed SNPs with info score< 0.5 were also excluded, and imputed genotypes called
with less than 90% confidence were coded as missing. Analyses were performed with PLINK
and R.
Maternal age effect. Because of the strong maternal age effect in maternal chromosome
21 nondisjunction, it is important to consider how maternal age fits into the above analyses.
Previous results from our group and others suggest not only different etiologies for MI and
MII nondisjunction, but likely different etiologies in different age groups. Statistically, this
would suggest a model that includes not only maternal age effect but also an age X genotype
interaction term. However, since our primary analyses compare mothers to fathers, it is not
possible to fit such a model (since fathers have no “maternal age”). The logical analysis, then, is
to stratify by maternal age group, similar to the approach we took for the MI and MII sub-
groups. We performed several such analyses, but the sample sizes were prohibitively small for
interpretation. We elaborate further on this issue in the Discussion.
Candidate gene analyses. For candidate gene analyses, we examined a window of 60kb
on each side of the gene or SNP. We used a statistical significance cutoff based on the method
of Li and Ji [46], which calculates the equivalent number of independent SNPs in the region
and applies a Bonferroni correction based on that number. Thus the candidate gene analyses
are fully corrected for multiple testing at the level of each individual gene.
Follow-up analyses to examine top-ranked GWAS signals. For follow-up analyses of sig-
nals of p< 10−5 for the GWAS, we performed literature searches on genes within 500kb. For
each of those regions, LocusZoom plots were created in all analyses to identify common associ-
ations across analyses.
Results
Candidate gene association studies
We focused on two sets of candidate genes/regions: genes that function in early stages of meio-
sis and that have been associated with accurate chromosome segregation (n = 24) and regions
associated with human recombination genome-wide counts (n = 8) [33]. The Bonferroni-cor-
rected statistical significance cutoffs along with all results are shown in Table 2 and Locus-
Zoom plots are provided in Figs 1–5 and in the Supporting Information (S2–S9 Figs). Each
row in Table 2 represents one candidate locus. Each column represents an analysis. For each
cell in the table, the most significant association at the locus (not always unique) is reported. P-
values significant after correcting for multiple testing are marked with an asterisk and
highlighted. Note that for each analysis in each gene, Table 2 lists the most statistically signifi-
cant result, so that the SNP that appears in a given gene is not necessarily the same in each
analysis. More detailed results are shown in the Supporting Information (S2 Table).
Candidate genes associated with chromosome segregation. These genes are shown in
the top half (above the double line) of Table 2. Examination of genes involved in the meiotic
cohesion complex showed a statistically significant association with RAD21L, a meiosis-
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Table 2. Candidate gene results.
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HORMAD1 P = 0.0152 P = 0.0174 P = 0.011377 P = 0.00361 1.35e-03
HORMAD2 P = 0.0113 P = 0.0156 P = 0.00155 P = 0.00838 8.93e-04
MEI1 P = 0.00655 P = 0.0485 P = 0.00951 P = 0.0204 9.26e-04
MEI4 P = 0.0147 P = 0.0164 P = 0.0283 P = 0.021 6.33e-04
MLH1 P = 0.0151 P = 0.00297 P = 0.0162 P = 0.0427 1.14e-03
MLH3 P = 0.00472 P = 0.0107 P = 0.0241 P = 0.0207 1.35e-03
MND1 P = 0.0273 P = 0.013 P = 0.000336� P = 9.6e-05� 8.77e-04
MSH5 P = 0.00677 P = 0.00135 P = 0.0417 P = 0.0241 9.26e-04
REC114 P = 0.0187 P = 0.0272 P = 0.0886 P = 0.0118 8.77e-04
REC8 P = 0.00822 P = 0.00404 P = 0.00195 P = 0.00112 9.43e-04
SMC1B P = 0.0115 P = 0.00407 P = 0.047 P = 0.0349 7.81e-04
SPO11 P = 0.0232 P = 0.0325 P = 0.0115 P = 0.0181 1.25e-03
STAG3 P = 0.005 P = 0.00472 P = 0.0798 P = 0.00958 1.19e-03
TRIP13 P = 0.0026 P = 0.0122 P = 0.00358 P = 0.0206 1.61e-03
rs1254319
(C14orf39 missense)
P = 0.0278 P = 0.0488 P = 0.0372 P = 0.00464 1.39e-03
rs75502650
(CCDC43 intron)
P = 0.00203 P = 0.00137� P = 0.000628� P = 0.031 7.58e-04
rs1132644
(CCNB1IP1 UTR)
P = 0.0232 P = 0.00657 P = 0.0236 P = 0.0195 1.32e-03
rs56162163
(chr17 inversion)
P = 0.00666 P = 0.00956 P = 0.00737 P = 0.0166 6.67e-04
rs74434767
(CPLX1 intron)
P = 0.00611 P = 0.0178 P = 0.0227 P = 0.0329 1.61e-03
rs5745459
(MSH4 missense)
P = 0.0389 P = 0.0283 P = 0.037 P = 0.0198 1.16e-03
rs150798754
(PRDM9 intergenic)
P = 0.00219 P = 0.006 P = 0.0123 P = 0.022 1.25e-03
rs6889665
(PRDM9 upstream)
P = 0.00219 P = 0.006 P = 0.0104 P = 0.0678 8.33e-04
rs450739
(RAD21L missense)
P = 2.49e-05� P = 7.47e-05� P = 0.00579 P = 0.00126 1.09e-03
rs4045481
(RNF212 missense)
P = 0.00475 P = 0.0136 P = 0.00514 P = 0.0131 1.02e-03
rs658846
(RNF212 intron)
P = 0.00292 P = 0.0108 P = 0.00514 P = 0.0131 8.33e-04
rs12233733
(RNF212 nearby)
P = 0.00292 P = 0.0108 P = 0.00396 P = 0.031 1.52e-03
(Continued)
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specific member of the α-kleisin protein family [47–50]. This was significant in both the moth-
ers vs. fathers and the MI mothers vs. fathers comparisons, and has a similar effect (odds ratio)
in the MII cases at the same SNP (Fig 1). Meiotic cohesins are essential for sister chromatid
cohesion, but also have an effect on other prophase I processes, including formation of the
axial/lateral elements, assembly of the SC, and crossing-over (e.g., [51, 52]). Gene disruption of
RAD21L leads to sexually dimorphic phenotypes in mice. Male mice are infertile, whereas
female mice show age-related infertility, reminiscent of primary ovarian insufficiency. The
reduced efficiency in synapsis in fetal oocytes may result in a lower ovarian reserve to be estab-
lished [50] In human males, variants in RAD21L have been implicated in meiotic arrest and
Sertoli cell-only syndrome [53].
Variants in seven genes coding for components of the SC were also investigated in this can-
didate gene group. Of the genes coding for components of the central element of the SC (i.e.,
SYCE1, SYCE2, SYCE3, TEX12), SYCE2 showed a statistically significant association (in the
MI mothers vs. fathers) (Fig 2), although the association with SYCE3 was close to the cutoff for
significance (also in MI mothers vs. fathers).
The other SC genes we examined code for the transverse filament (SYCP1) and components
of the axial/lateral elements (SYCP2 and SYCP3). SYCP1 showed significant association in the
MI vs. MII analysis, but not in the other analyses (Fig 3). The signal in SYCP1 was primarily
located at an imputed SNP, at rs35401563, so this result requires confirmation by further geno-
typing. SYCP2 showed highly significant associations in both the MII mothers vs. fathers and
the MI vs. MII comparisons (Fig 4), suggesting the potential for an effect specific to MII.
SYCP3 was nearly significant in the MI vs. MII comparison.
Among the other candidate genes in this group, the only statistically significant result was
for MND1. The observed significant association was strongest in the MI vs. MII comparison,
was also strong in the MII vs. fathers comparison, and was much weaker in the MI vs. fathers
comparison. This pattern suggests that this locus may be associated with MII nondisjunction.
Based on genetic and cellular analysis of deletion mutants, MND1, acting with HOP2, plays a
role in the initial processing of DSBs. Specifically, the HOP2-MND1 complex is involved in
two separate stages of the DMC1-promoted recombination process: first, in the stabilization of
DMC1 filaments on the resected end of the DSBs, and second, in the promotion of the subse-
quent strand invasion steps. In higher eukaryotes (mouse [54] and Arabidopsis thaliana [55,
56]), MND1 appears to be required for normal male and female fertility. Mutations result in
normal recombination initiation, but meiotic DSBs are abnormally repaired and chromosome
synapsis is aberrant [17]. The HOP2-MND1 complex has also been implicated in ovarian dys-
function and biochemically, is capable of driving RAD51-mediated alternative lengthening of
telomeres in somatic cells [57]. If this association is confirmed, understanding why the effect
of the variant is stronger in MII errors vs. MI errors may shed more light on its function.
Table 2. (Continued)












P = 0.0125 P = 0.007 P = 0.00306 P = 0.000183� 1.39e-03
Each row represents one candidate locus (either a gene with a 60kb border on each side or a 60kb window around a SNP). Each column represents an analysis. For each
locus-analysis pair, the most significant association at the locus (not always unique) is reported. P-values significant after correcting for multiple testing (i.e., exceeding
the Bonferroni-adjusted significance threshold noted in the last column) are marked with an asterisk and highlighted. (MI: meiosis I; MII: meiosis II; P: p-value; OR:
odds ratio.) The first 24 loci represent genes selected for their function (above the double line). The latter 13 loci represent SNPs identified by Kong et al. in their GWAS
of recombination [33], with annotation in parentheses (below the double line).
https://doi.org/10.1371/journal.pgen.1008414.t002
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Genes associated with human genome-wide recombination counts (shown in the bot-
tom half of Table 2, below the double line of Table 2). We also examined the eight regions
identified in Kong et al. that were highly associated with genome-wide recombination counts
in a large Icelandic study of 71,929 parent-offspring pairs [33]. Of the eight regions, three
showed associations with maternal nondisjunction that were statistically significant according
to the cutoffs shown in Table 2. The first region included RAD21L for which results are dis-
cussed above, as it was also in the group of candidate genes for meiotic processes. The second
statistical signal was in the region of SMEK1 (also known as protein phosphatase 4 regulatory
subunit 3 (PPP4R3A)) and was strongest in the MI vs. MII mothers comparison (Fig 5).
SMEK1 is known as a regulator of cellular functions, including apoptosis, cell growth, micro-
tubule organization, cell cycle arrest, and TNF and PI3K/Akt signaling (e.g., [58, 59]). It is also
known to play a role in endothelial cell function and subsequent angiogenesis [60]. However,
its role in meiosis is unknown, although it is known to be expressed in the ovary.
The third signal is in the region of CCDC43, and was evident in both the MI mothers vs.
fathers analysis and the MII mothers vs. fathers analysis (see S7 Fig). There is no known func-
tion of CCDC43 in meiosis. In the study of Kong et al. [33], the SNP associated with recombi-
nation (rs75502650) was located in an intron of CCDC43. It was estimated to increase the
global recombination rate by 76 cM and this effect was limited to females.
Strongest results from the genome-wide association study
Because of the limited sample size in this study, the full GWAS produced only suggestive
results, though a few of those top results have strong support in the literature for the relevance
of the gene functions to meiosis or fetal survival. Manhattan plots and Q-Q plots for each
GWAS analysis are included in the Supporting Information (S10 Fig). Tables 3–7 show the
most statistically significant results from each of the comparisons in the genome-wide associa-
tion study. For each result for a given comparison, the corresponding table also gives the small-
est p-value within 20kb in each of the other comparisons. Detailed results are included in the
Supporting Information (S3–S7 Tables).
rs10948101 on chromosome 6 near VEGFA. The observed signal for this locus was stron-
gest for the analysis of all mothers vs. fathers and was located within LOC100132354, a long
non-coding RNA (lncRNA) (Fig 6). Upstream of this intergenic lncRNA is VEGFA, the gene
encoding vascular endothelial growth factor A (VEGFA). In a recent meta-analysis,
LOC100132354 was confirmed to be highly associated with VEGF circulating levels in serum
[61]. VEGFA plays multiple roles in ovarian development and function (reviewed in McFee
and Cupp [62]). Vascularization plays a role in the formation of early ovarian structures, pri-
mordial follicle assembly, and follicle activation. Further, ovarian function is highly dependent
on the development and continual remodelling of a complex vascular system. This allows the
follicle and the corpus luteum to receive the needed oxygen, nutrients, and systemic hormones
and the release of ovarian hormones (reviewed in Robinson et al. [63]). If angiogenesis is dis-
rupted, follicular growth is reduced, ovulation is perturbed, and development and function of
the corpus luteum is significantly altered. The action of VEGFA is necessary at all these stages
of development. We did not see any significant effect in the TDT analysis, so there is no sug-
gestion that this locus is associated with survival to term.
Fig 1. LocusZoom plot for RAD21L. In this Figure (as in Figs 2–12) four LocusZoom plots show the results at one
locus across all four analyses. Each point is one variant, with the x- and y-axes representing physical position on the
chromosome and -log10(p-value), respectively. Open squares and asterisks represent genotyped and imputed variants,
respectively. Coloring represents linkage disequilibrium (red = stronger, blue = weaker) with the tagging SNP (which is
purple). The overlaid blue curve shows the recombination rate.
https://doi.org/10.1371/journal.pgen.1008414.g001
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Fig 2. LocusZoom plot for SYCE2.
https://doi.org/10.1371/journal.pgen.1008414.g002
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rs11535058 on chromosome 2 near SLC39A10. The observed signal in this region, stron-
gest in the mothers vs. fathers comparison, was located 132kb downstream of SLC39A10 (Fig
7), with a similar, but non-significant, effect size for both MI mothers vs. fathers and MII
mothers vs. fathers. SLC39A10 is involved in the zinc transport network. Regulation of intra-
cellular zinc is essential for oocyte maturation and activation. In mouse, progression of the
oocyte from a cell arrested in prophase of MI into a mature egg arrested at metaphase of MII is
accompanied by an increase in total zinc content. This increase is required for proper meiotic
progression [64]. Also, exit from MII during oocyte activation requires decreasing cellular zinc
through the rapid export of zinc from the oocyte. These ‘zinc sparks’ are required for oocyte
activation and resumption of the cell cycle [65].
Fig 3. LocusZoom plot for SYCP1.
https://doi.org/10.1371/journal.pgen.1008414.g003
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Fig 4. LocusZoom plot for SYCP2.
https://doi.org/10.1371/journal.pgen.1008414.g004
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Fig 5. LocusZoom plot for SMEK1.
https://doi.org/10.1371/journal.pgen.1008414.g005
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Specific to SLC39A10, Lisle et al. [66] found a complex zinc transport network present in
the cumulus-oocyte complex in mouse oocytes. They found that mRNA transcripts for specific
zinc transporter proteins (SLC family), including Slc39a10 were higher in oocytes, while
another unique set of zinc transporter protein transcripts were higher in cumulus cells. Thus,
zinc homeostasis, regulated in the cumulus-oocyte complex, may affect both MI and MII
processes.
rs35288347 on chromosome 19 near AURKC. This signal occurs primarily in the MI
mothers vs. fathers analysis (Fig 8), with a similar but less significant effect in the mothers vs.
fathers analysis. Consistent with the possibility of an effect specific to MI, mutations in the
AURKC gene in this region (160kb away) cause tetraploidy in human sperm and MI arrest in
mouse oocytes [67, 68].
rs9984132 on chromosome 21 located in a gene rich region. The signal at rs9984132 on
chromosome 21 is located in a gene-rich region (Fig 9). The strongest signal at this locus was
Table 3. Top hits from the all mothers vs. fathers genome-wide association study.
Locus All mothers vs. fathers MI mothers vs. fathers MII mothers vs. fathers MI mothers vs.
MII mothers
TDT
rs10948101 P = 7.65e-07 P = 1.58e-06 P = 0.000897 P = 0.0634 P = 0.00514
rs35141718 P = 2.02e-06 P = 1.92e-05 P = 0.0109 P = 0.127 P = 0.0499
rs11535058 P = 2.42e-06 P = 2.1e-05 P = 7.69e-05 P = 0.0411 P = 0.015
rs62086686 P = 4.45e-06 P = 0.000292 P = 8.53e-05 P = 0.0171 P = 0.0133
rs75733466 P = 5.09e-06 P = 0.00023 P = 1.24e-05 P = 0.00189 P = 0.0212
rs117746305 P = 5.14e-06 P = 0.000168 P = 3.93e-06 P = 0.056 P = 0.0881
rs12947774 P = 5.62e-06 P = 0.000199 P = 0.000949 P = 0.00229 P = 0.0339
rs1612273 P = 5.93e-06 P = 7.22e-05 P = 1.62e-05 P = 0.000934 P = 0.00432
rs12652455 P = 6.43e-06 P = 2.43e-05 P = 0.000437 P = 0.0429 P = 0.0518
rs148846406 P = 6.79e-06 P = 3.85e-05 P = 0.00673 P = 0.0562 P = 0.00883
rs11026040 P = 8.22e-06 P = 0.000238 P = 3.1e-05 P = 0.00505 P = 0.00794
rs7010571 P = 8.27e-06 P = 3.41e-05 P = 0.0185 P = 0.0796 P = 0.0477
rs35816728 P = 9.96e-06 P = 6.09e-05 P = 0.00101 P = 0.00124 P = 0.00815
Suggestive associations (p < 10−5) are recorded (highlighted cells). For each such locus, the most significant association within 20kb is recorded for each of the other
four genome-wide analyses. Rows are ordered by significance. (MI: meiosis I; MII: meiosis II; P: p-value.)
https://doi.org/10.1371/journal.pgen.1008414.t003
Table 4. Top hits from the MI mothers vs. fathers genome-wide association study.
Locus All mothers vs. fathers MI mothers vs. fathers MII mothers vs. fathers MI mothers vs. MII mothers TDT
rs10948100 P = 7.65e-07 P = 1.58e-06 P = 0.000897 P = 0.0634 P = 0.00514
rs35288347 P = 1.26e-05 P = 2.72e-06 P = 0.023 P = 0.0298 P = 0.0339
rs4649043 P = 0.000148 P = 3.1e-06 P = 0.00388 P = 0.000408 P = 0.00556
rs437933 P = 1.79e-05 P = 3.29e-06 P = 0.0683 P = 0.05 P = 0.0186
rs16847735 P = 2.44e-05 P = 3.77e-06 P = 0.0173 P = 0.0135 P = 0.0617
rs2467011 P = 5.02e-05 P = 4.29e-06 P = 0.0902 P = 0.00786 P = 0.158
rs9442389 P = 1.88e-05 P = 5.27e-06 P = 0.0701 P = 0.0164 P = 0.0241
rs731245 P = 0.000148 P = 6.91e-06 P = 0.00772 P = 0.000809 P = 0.00654
rs984968 P = 1.48e-05 P = 6.95e-06 P = 0.0741 P = 0.0425 P = 0.0833
rs9984132 P = 5.86e-05 P = 9.87e-06 P = 0.0539 P = 0.00662 NA
Suggestive associations (p < 10−5) are recorded (highlighted cells). For each such locus, the most significant association within 20kb is recorded for each of the other
four genome-wide analyses. Rows are ordered by significance. (MI: meiosis I; MII: meiosis II; P: p-value.)
https://doi.org/10.1371/journal.pgen.1008414.t004
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identified in the comparison of MI mothers with fathers. Two genes stand out as possible can-
didates for involvement in chromosome segregation. COL6A2, located 34kb upstream of the
signal, codes for one of the components of collagen that is part of the extracellular matrix
(ECM) formed by cumulus cells. This ovarian follicular ECM is related to proliferation, ste-
roidogenesis, and luteinization [69]. As the formation of this ECM is involved in fertilization
and embryo quality, the observation that this signal appears to be only related to MI nondis-
junction reduces the support of COL6A2 as a candidate.
PCNT is a gene located about 260kb upstream from the signal. Pericentrin, coded by PCNT,
is a highly conserved component of the acentriolar microtubule-organizing centers (aMTOCs)
in mouse oocytes. aMTOCs play a vital role in meiotic spindle assembly and stability. Deple-
tion of pericentrin in mouse oocytes leads to increased rates of aneuploidy [70]. Human
Table 5. Top hits from the MII mothers vs. fathers genome-wide association study.
Locus All mothers vs. fathers MI mothers vs. fathers MII mothers vs. fathers MI mothers vs. MII mothers TDT
rs1855111 P = 6.48e-05 P = 0.00213 P = 2.2e-06 P = 0.00698 P = 0.00494
rs76740710 P = 7.19e-06 P = 0.000236 P = 3.93e-06 P = 0.0341 P = 0.00648
rs12981234 P = 0.0013 P = 0.00911 P = 4.28e-06 P = 8.8e-05 P = 0.0854
rs200216460 P = 0.000209 P = 0.0104 P = 4.99e-06 P = 0.00373 P = 0.00284
rs11668205 P = 0.00588 P = 0.00218 P = 5.49e-06 P = 3.34e-05 P = 0.0233
rs146838878 P = 0.0197 P = 0.0249 P = 6.16e-06 P = 0.000328 P = 0.000463
rs115281615 P = 0.047 P = 0.0792 P = 6.34e-06 P = 7.33e-07 P = 0.0712
rs62359711 P = 0.0024 P = 0.00108 P = 6.91e-06 P = 0.000191 P = 0.0112
rs73178888 P = 0.00754 P = 0.0041 P = 7.05e-06 P = 1.72e-05 P = 0.0122
rs9966603 P = 0.00967 P = 0.0639 P = 7.05e-06 P = 0.00208 P = 0.00759
rs13020106 P = 0.00149 P = 0.0335 P = 7.12e-06 P = 0.00336 P = 0.0162
rs2560850 P = 0.0016 P = 0.00365 P = 7.69e-06 P = 0.000332 P = 0.00604
rs1191234 P = 0.00176 P = 0.0137 P = 9.98e-06 P = 0.00157 P = 0.0411
Suggestive associations (p < 10−5) are recorded (highlighted cells). For each such locus, the most significant association within 20kb is recorded for each of the other
four genome-wide analyses. Rows are ordered by significance. (MI: meiosis I; MII: meiosis II; P: p-value.)
https://doi.org/10.1371/journal.pgen.1008414.t005
Table 6. Top hits from the MI mothers vs. MII mothers genome-wide association study.
Locus All mothers vs. fathers MI mothers vs. fathers MII mothers vs. fathers MI mothers vs. MII mothers TDT
rs115281615 P = 0.047 P = 0.0792 P = 6.34e-06 P = 7.33e-07 P = 0.0712
rs6440985 P = 0.0958 P = 0.0112 P = 0.000198 P = 1.31e-06 P = 0.00796
rs2806747 P = 0.0934 P = 0.0656 P = 0.00037 P = 1.35e-06 P = 0.00284
rs9319652 P = 0.0225 P = 0.0267 P = 0.00243 P = 4.09e-06 P = 0.039
rs11977478 P = 0.00474 P = 0.00902 P = 0.00019 P = 4.18e-06 P = 0.00232
rs11034351 P = 0.0124 P = 0.00284 P = 7e-04 P = 4.3e-06 P = 0.0295
rs7685548 P = 0.00618 P = 0.000955 P = 0.00884 P = 4.82e-06 P = 0.00226
rs71967233 P = 0.044 P = 0.0785 P = 0.000135 P = 5.24e-06 P = 0.0163
rs34282937 P = 0.0334 P = 0.0368 P = 5.95e-05 P = 5.48e-06 P = 0.0298
rs77525287 P = 0.0707 P = 0.000444 P = 0.0124 P = 5.9e-06 P = 0.099
rs4818884 P = 0.0454 P = 0.0312 P = 0.00354 P = 9.57e-06 NA
rs61999085 P = 0.00851 P = 0.000125 P = 0.0449 P = 9.84e-06 P = 0.00243
Suggestive associations (p < 10−5) are recorded (highlighted cells). For each such locus, the most significant association within 20kb is recorded for each of the other
four genome-wide analyses. Rows are ordered by significance. (MI: meiosis I; MII: meiosis II; P: p-value.)
https://doi.org/10.1371/journal.pgen.1008414.t006
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oocytes differ from mouse oocytes in that they lack PNCT and aMTOCs in MI, where spindle
assembly is mediated from chromosomes by the small guanosine triphosphates [71]. Thus,
more work is needed to confirm this signal and its underlying genetic association.
rs73178888 on chromosome 8 near a region associated with meiotic recombination.
This signal, located in an intron of ERICH1, is primarily observed in the MII mothers vs.
fathers analysis and in the MI vs. MII analysis, suggesting that it might be an MII risk locus
(Fig 10). The location is noteworthy because Begum et al. [72] identified a variant 59kb away
in this region as potentially associated with meiotic recombination (specifically recombination
outside of hotspots) in a euploid population. There is no evidence to suggest that ERICH1 or
DLGAP2 (also known as ERICH1-AS1), 3kb from the signal, is involved in recombination or
meiosis. The next closest gene is TDRP. The deficiency of TDRP in mice is suggested to be
involved in sperm motility and may play a role in spermatogenesis [73], but there is no evi-
dence for involvement is oogenesis.
rs115281615 on chromosome 4 near CPEB2. The signal at this locus is primarily
observed in the MII mothers vs. fathers comparison (Fig 11). The genes in the region,
C1QTNF7, and CC2D2A, do not have evidence for a role in meiosis. CPEB2, located 193kb
from the signal, encodes an RNA-binding protein, cytoplasmic polyadenylation element bind-
ing protein and is thought to be involved in regulated translation, a system that allows the
rapid production of selective proteins in response to a physiological signal. CPEB2 interacts
with the elongation factor, eEF2, to slow down peptide elongation of CPEB2-bound RNA [74].
In mice, this protein is highly similar to the family of CPEBs that regulate cytoplasmic polyade-
nylation of mRNA as a trans-factor in oogenesis and spermatogenesis. CPEB2 is expressed
post-meiotically in mouse spermatogenesis, which suggests a possible role in translational reg-
ulation of stored mRNAs in transcriptionally inactive haploid spermatids [75].
rs2560850 on chromosome 5 in an intron of MYO10. The comparison between MII
mothers vs. fathers shows the strongest statistical significance for this locus which includes
MYO10 (Fig 12). Myosin-10 proteins are phosphoinositide-binding, actin-based motors that
play an important role during meiosis in the integration of the F-actin and microtubule
Table 7. Top hits from the TDT (transmission disequilibrium test) genome-wide association study.
Locus All mothers vs. fathers MI mothers vs. fathers MII mothers vs. fathers MI mothers vs. MII mothers TDT
rs3802065 P = 0.0144 P = 0.0066 P = 0.0318 P = 0.00859 P = 4.84e-07
rs2867076 P = 0.0164 P = 0.0227 P = 0.0081 P = 0.00904 P = 1.05e-06
rs7451700 P = 0.0186 P = 0.0169 P = 0.0544 P = 0.0195 P = 1.71e-06
rs7389783 P = 0.0421 P = 0.0397 P = 0.00488 P = 0.00741 P = 1.93e-06
rs17769147 P = 0.182 P = 0.152 P = 0.0738 P = 0.0624 P = 2.06e-06
rs201634098 P = 0.00592 P = 0.00385 P = 0.0722 P = 0.015 P = 3.52e-06
chr23:154539980 NA NA NA NA P = 3.63e-06
rs74615884 P = 0.0801 P = 0.037 P = 0.0167 P = 0.00236 P = 3.73e-06
rs158866 P = 0.036 P = 0.00582 P = 0.0103 P = 0.0102 P = 3.77e-06
rs1187600 P = 0.0553 P = 0.0636 P = 0.204 P = 0.156 P = 6.25e-06
rs55743346 P = 0.0514 P = 0.0371 P = 0.0834 P = 0.0234 P = 7.34e-06
rs183199067 P = 0.0131 P = 0.00285 P = 0.0396 P = 0.0254 P = 9.55e-06
rs140022090 P = 0.0163 P = 0.00733 P = 0.0538 P = 0.00493 P = 9.55e-06
rs34518363 P = 0.00538 P = 0.00186 P = 0.049 P = 0.0394 P = 9.55e-06
rs6681167 P = 0.0358 P = 0.0505 P = 0.0648 P = 0.0377 P = 9.58e-06
Suggestive associations (p < 10−5) are recorded (highlighted cells). For each such locus, the most significant association within 20kb is recorded for each of the other
four genome-wide analyses. Rows are ordered by significance. (MI: meiosis I; MII: meiosis II; P: p-value.)
https://doi.org/10.1371/journal.pgen.1008414.t007
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cytoskeletons. Proper spindle positioning and orientation are essential for asymmetric cell divi-
sion and these functions are particularly important in meiosis. In Xenopus oocytes, Weber et al.
[76] showed that myosin-10 is associated with microtubules and is concentrated where the mei-
otic spindle contacts the F-actin-rich cortex. This observation and others suggest that myosin-
10, the microtubule-binding myosin, is required for anchoring the spindle and an actin-binding
kinesin is required for meiotic cytokinesis [76, 77]. Recently F-actin was shown to permeate the
microtubule spindles in oocytes of many mammals, including human, where it prevents lagging
chromosomes and thus segregation errors, including during anaphase I [78].
Fig 6. LocusZoom plot for VEGFA.
https://doi.org/10.1371/journal.pgen.1008414.g006
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Fig 7. LocusZoom plot for SLC39A10.
https://doi.org/10.1371/journal.pgen.1008414.g007
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Fig 8. LocusZoom plot for AURKC.
https://doi.org/10.1371/journal.pgen.1008414.g008
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Fig 9. LocusZoom plot for rs9984132 on chromosome 21.
https://doi.org/10.1371/journal.pgen.1008414.g009
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Fig 10. LocusZoom plot for DLGAP2.
https://doi.org/10.1371/journal.pgen.1008414.g010
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Fig 11. LocusZoom plot for CPEB2.
https://doi.org/10.1371/journal.pgen.1008414.g011
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Fig 12. LocusZoom plot for MYO10.
https://doi.org/10.1371/journal.pgen.1008414.g012
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Strongest results from the TDT analyses
Together with the other case/control association tests to identify genes associated with nondis-
junction, we also had the opportunity to use the TDT. We assumed that the TDT might help
tease apart genes associated with nondisjunction from those associated with fetal “survival
genes.” If there is association between maternal genotype and either nondisjunction or sur-
vival, this test can theoretically identify it. We only performed this test in our GWAS approach,
not our candidate genes, since the candidates were chosen for possible involvement in nondis-
junction per se. Here we highlight two genes where the statistical signal was relatively strong,
although not genome-wide significant.
The first is located at rs17769147, 24kb upstream of the gene RNF182, which encodes a
RING-finger-containing transmembrane protein that includes an E3 ubiquitin ligase activity.
There was no statistical signal for any of the case/control comparisons, only for the TDT. Stud-
ies have shown that this gene is expressed preferentially in the brain and is up-regulated in Alz-
heimer’s disease brain and in neuronal cell cultures that are subject to stress-induced cell death
[79]. In another line of study, RNF182 was found to be one of the gene targets of MeCP2, the
gene involved in Rett syndrome. The group of identified gene targets are involved in the regu-
lation of the cell growth and survival of neuronal cells [80].
Another strong TDT signal was found at rs158866, with no statistical signal for any of the
case/control comparisons. This signal is located within NEDD4L (also referred to as NEDD4-
2), a gene encoding a ubiquitin ligase. This protein binds and regulates membrane-associated
proteins (although not exclusively), particularly ion channels and transporters (reviewed in
Goel et al. [81]). NEDD4L interacts with several other proteins and may regulate other impor-
tant substrates as well (e.g., [82, 83]). Based on current evidence, this ligase is essential for the
maintenance of cellular homeostasis.
Discussion
We present, for the first time, a candidate gene study and GWAS of chromosome 21 maternal
nondisjunction. The goal of this project was to gain insight into factors that may predispose a
woman to this common chromosomal error.
Genes associated with cohesin complex
The meiosis-specific cohesin subunits are encoded by SMC1β, REC8, RAD21L, and STAG3. Of
these genes, we found that variation in RAD21L was associated with nondisjunction, with the
strongest signal with MI nondisjunction. As part of the cohesion complex [47–50], RAD21L
plays a role in the structural maintenance of chromosomes (SMC) complex. The SMC complex
includes cohesin, condensin and SMC5/6, and is an important regulator of chromosome
dynamics and structure during both mitosis and meiosis. In female mice, mutations in meio-
sis-specific cohesins and in the SMC complex increase the frequency of oocyte aneuploidy and
primary ovarian insufficiency [50, 84–86]. The study of Kong et al. [33] found a highly signifi-
cant association of RAD21L with male recombination and a much weaker signal in females;
Begum et al. [72] did not replicate this finding, although the genomic region had poor cover-
age in two of the three datasets of their study. Together, this suggests a sex-specific role of
RAD21L and one in females that maybe more directly related to segregation of bivalents than
recombination counts per se.
There are several possible explanations for why genetic variation in RAD21L was associated
with maternal nondisjunction whereas variation in REC8 was not, although both are α-kleisin
subunits that are part of the cohesin complex. One possible explanation is that there is reduced
power to detect a signal based on allele frequencies of variants in REC8 compared with
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RAD21L. Alternatively one gene may play a more essential role in meiosis, where variation is
not tolerated or not compatible with the oocyte surviving to fertilization. It is known that these
genes play unique roles during meiosis and thus have differential effects on the meiotic process
[87–89].
Genes associated with the synaptonemal complex (SC)
The general structure of the SC is highly conserved across yeast and mammals, although the
genes and proteins involved are not always conserved (reviewed in Cahoon and Hawley [10]).
The tripartite protein structure extends along the entire length of the synapsed homologues
and assembles alongside cohesin and cohesin-like proteins that hold the sister chromatids of
the homologues together (e.g., [90, 91]). Mutations in genes coding for SC components have
been identified previously among women with infertility or recurrent miscarriages (reviewed
in Geisinger and Benavente [92]). At this time, only mutations in SYCP3 and SYCE1 have
been identified, but most studies had<100 women available for study. In our study, we found
evidence for an association of variants in genes of all three SC components with maternal non-
disjunction. We had supporting evidence for SYCP3 (although not statistically significant),
with the strongest statistical signal being found in the comparison of MI vs. MII. In addition,
we found a statistically significant association of SYCE2 in MI vs. fathers and with SYCP2 in
the comparison of MI vs. MII. Thus, with an increased sample size and a more homogeneous
reproductive outcome, we were able to confirm the importance of the SC structure for proper
segregation of chromosome during human oogenesis.
Association with recombination-related variants
It is now well established that there is both significant sex-specific and individual variation in
genome-wide recombination counts and location of events, in spite of the need for the recom-
bination process to be tightly controlled [93–95]. When there are alterations in the number of
recombinants (reduced or no recombination) or their location (pericentromeric or telomeric),
there is a high risk for human chromosome nondisjunction [96–98]. Variation in genes that
play a role in recombination has been identified and we examined those that were identified in
a large Icelandic study using linkage analyses of live births [33]. Begum et al. [72] also
attempted to replicate the association of these variants in a population of primarily Northern
European ancestry. Their GWAS meta-analyses were extended to the study of recombination
phenotypes, including the average recombination count along with those related to placement
relative to historical recombination hotspots. Here, we asked whether these variants would
also explain susceptibility to maternal nondisjunction. Our results are interesting both with
respect the identification of associated regions and to the lack of evidence in the others.
Both Kong et al. [33] and Begum et al. [72] found a strong association of SMEK1 (also known
as PPP4R3A) with recombination in females only. Our results identified the strongest association
in the comparison of MI vs. MII nondisjunction, which suggests a stage-specific role of this pro-
tein, as well as a sex-specific role identified in the recombination studies. At this time, there is no
known role of SMEK1 in meiosis. It is a member of the PP2A subfamily. PP2A is involved in de-
protection of centromere cohesin in MII of mammals, a process that is essential for proper sister
chromatid segregation (reviewed in Wassmann [99]). Although it is intriguing to think that varia-
tion in SMEK1 may alter this MII-associated process, this is no direct link at this time.
Another locus that deserves follow-up is on chromosome 8 near rs73178888, one of the top
hits in our genome-wide analyses. Begum et al. [72] identified this same region as potentially
associated with meiotic recombination in a euploid population. Although the genes in the
region do not appear to be linked to recombination, further investigation is warranted.
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With respect to the two most well-established genes associated with recombination,
RNF212 and PRDM9, our data showed no association with nondisjunction. Variation in
RNF212 is sex-specific, some variants being associated with increased recombination in males
and others in females [33, 70, 95, 100–102]. RNF212 is known to form many discrete foci
along chromosomes early in meiotic prophase I; these foci are then reduced to a few sites
where crossovers are formed [103]. For small chromosomes such as chromosome 21, perhaps
female-specific variation in this process is less evident compared with genome-wide
alterations.
Variation in PRDM9 is known to be associated with recombination hotspots in both males
and females. Kong et al. [33] showed that variants were also associated with total recombina-
tion counts in males, but not females. Begum et al. [72] provided further evidence that in
females, variants were associated with both recombinant counts within and outside of histori-
cal hotspots, in opposite directions. They suggested that females might have a compensatory
mechanism, such that increased recombination in hotspots is balanced by decreased recombi-
nation elsewhere; thereby not altering the overall recombination count. In males, variants
were only associated with recombinants within historical hotspots. In our previous study, we
found that historical hotspot usage along maternally-derived nondisjoined chromosomes 21
was similar to that in controls, particularly among MI errors, indicating that the observed
altered telomeric placement probably does not involve differential hotspot usage [28]. Subse-
quently, Oliver et al. [104] studied sequence variation in the zinc finger-binding domain
(ZFBD) of PRDM9 in a subset of the study sample presented here. They found that the fre-
quency of the PRDM9 ZFBD minor alleles was significantly increased among women who had
a chromosome 21 nondisjunction event and no observed recombination on 21q. Further,
when these PRDM9 minor alleles were compared with the major A-allele, fewer predicted
binding sites on 21q were found. Together, these observations suggest that allelic variation in
PRDM9 may play a role in nondisjunction, but that the effect size may be small and it may be
limited to nondisjunction of achiasmate chromosomes.
Gene discovery
When we conducted a GWAS, no variants were genome-wide significant; thus, the marginally
significant signals need replication prior to additional speculation. We highlighted a few find-
ings in Results for signals in genes that are known to be involved in oogenesis. If these are true
signals, our data are consistent with the idea that the underlying susceptibility for chromosome
nondisjunction involves different components of oogenesis.
Conclusion and future direction
Our candidate gene study was successful in detecting statistically significant associations of
maternal nondisjunction of chromosome 21 and variation in genes that are essential for
proper chromosome segregation during meiosis. Future studies are needed to investigate
other known risk factors and their interaction with the genetic variation. For example, stratifi-
cation by maternal age at the time of birth of the infant with trisomy 21 could provide insight
into mechanism of the identified genetic variants. In our exploratory analyses, we did not
observe unique age-associated variants; however, our sample sizes were limited. Thus, expan-
sion of the study sample with enrichment of the youngest and oldest maternal age groups
would be valuable. Also, studies that further stratify meiotic errors by recombination risk pat-
terns known to increase susceptibility of nondisjunction, namely lack of observed recombina-
tion, a single telomeric recombination event or a pericentromeric event, may provide further
insight into the function of the genetic variant.
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Another possible approach is to examine other sources of samples from which information
on aneuploidy may be drawn to obtain larger sample sizes. For example McCoy et al. [105]
studied day-3 embryos obtained from in vitro fertilization cycles and parents to identify both
meiotic and mitotic segregation errors. Irrespective, we have begun to gain insight into which
meiotic proteins may be more susceptible to genetic variation, leading to abnormal chromo-
some segregation. Independent studies are needed to replicate findings from our GWAS study
to further identify novel susceptibility genes.
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a gene with a 60kb border on each side or a 60kb window around a SNP). Each column repre-
sents an analysis. For each locus-analysis pair, the most significant association at the locus (not
always unique) is reported. P-values significant after correcting for multiple testing (i.e.,
exceeding the Bonferroni-adjusted significance threshold noted in the last column) are marked
with an asterisk and highlighted. (MI: meiosis I; MII: meiosis II; P: p-value; OR: odds ratio.)
The first 24 loci represent genes selected for their function (above the double line). The latter
13 loci represent SNPs identified by Kong et al. in their GWAS of recombination [33], with
annotation in parentheses (below the double line). Note that for each analysis in each gene, S2
Table lists the most statistically significant result within a window, so that the SNP that appears
in a given gene is not necessarily the same in each analysis. This also means that some odds
ratios appear to “flip” between analyses; for example, a result that shows an odds ratio of 2.0
for one SNP in the MI vs. fathers analysis may be represented as an odds ratio of approximately
0.5 (i.e. 1/2.0) for a nearby SNP in the MII vs. fathers analysis.
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(MI: meiosis I; MII: meiosis II; P: p-value; OR: odds ratio).
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